Mitochondrial metabolic rescue in post-COVID-19 syndrome: MR spectroscopy insights and precision nutritional therapeutics
- PMID: 40486513
- PMCID: PMC12141278
- DOI: 10.3389/fimmu.2025.1597370
Mitochondrial metabolic rescue in post-COVID-19 syndrome: MR spectroscopy insights and precision nutritional therapeutics
Abstract
Post-COVID-19 Condition (PCC), impacting 30-90% of survivors, is characterized by persistent fatigue and metabolic dysfunction, often linked to underlying mitochondrial impairment. This review examines current evidence on mitochondrial-targeted nutrition therapies, with a focus on magnetic resonance spectroscopy (MRS) as a tool for assessing metabolic recovery. Key findings highlight reduced adenosine triphosphate (ATP) production, heightened oxidative stress, and disrupted mitochondrial biogenesis- metabolic abnormalities that closely mirror those seen in chronic fatigue syndromes. While mitochondrial dysfunction is recognized as central, debate continues on whether systemic inflammation or direct viral damage primarily drives these abnormalities. Current evidence supports nutrients, such as, CoQ10, NAC, and creatine for restoring energy metabolism and reducing oxidative stress. MRS biomarkers (τPCr, Qmax), offer valuable tools for monitoring personalized intervention. However, several limitations persist, including variability in nutritional protocols, inconsistencies in MRS methodologies, and limited consideration of microbiome-psychosocial interactions. Most clinical trials focus on short-term outcomes, lacking data on long-term efficacy or stratification based on mitochondrial dysfunction severity. Future research priorities include multi-omics investigations into mitochondrial-epigenetic interactions, the development of targeted antioxidants, and exploration of engineered microbial metabolites. Standardizing MRS protocols, validating composite endpoints, and optimizing nutrient delivery systems require interdisciplinary collaboration. This review advocates for a precision medicine approach, combining MRS-based metabolic profiling with personalized nutritional strategies, to address the multifactorial nature of PCC and advance clinical translation.
Keywords: magnetic resonance spectroscopy; mitochondrial dysfunction; nutrition; post-COVID-19 condition; precision medicine.
Copyright © 2025 Chen, Cai and Zheng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID.Radiology. 2024 Dec;313(3):e233173. doi: 10.1148/radiol.233173. Radiology. 2024. PMID: 39718498
-
Novel biomarkers of mitochondrial dysfunction in Long COVID patients.Geroscience. 2025 Apr;47(2):2245-2261. doi: 10.1007/s11357-024-01398-4. Epub 2024 Nov 4. Geroscience. 2025. PMID: 39495479 Free PMC article.
-
Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches.Geroscience. 2024 Oct;46(5):5267-5286. doi: 10.1007/s11357-024-01165-5. Epub 2024 Apr 26. Geroscience. 2024. PMID: 38668888 Free PMC article. Review.
-
Platelet mitochondrial function and endogenous coenzyme Q10 levels are reduced in patients after COVID-19.Bratisl Lek Listy. 2022;123(1):9-15. doi: 10.4149/BLL_2022_002. Bratisl Lek Listy. 2022. PMID: 34967652
-
Mitochondrial Dysfunction in Critical Illness: Implications for Nutritional Therapy.Curr Nutr Rep. 2019 Dec;8(4):363-373. doi: 10.1007/s13668-019-00296-y. Curr Nutr Rep. 2019. PMID: 31713718 Review.
Cited by
-
Post-COVID Condition and Neuroinflammation: Possible Management with Antioxidants.Antioxidants (Basel). 2025 Jul 8;14(7):840. doi: 10.3390/antiox14070840. Antioxidants (Basel). 2025. PMID: 40722944 Free PMC article. Review.
References
-
- Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Florêncio LL, Cuadrado ML, Plaza-Manzano G, et al. . Prevalence of post-covid-19 symptoms in hospitalized and non-hospitalized covid-19 survivors: A systematic review and meta-analysis. Eur J Internal Med. (2021) 92:55–70. doi: 10.1016/j.ejim.2021.06.009 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical